Biocure Technology Inc.
CUREX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.90K | 12.50K | 19.80K | 21.20K | 2.60K |
| Total Receivables | 4.90K | 5.40K | -- | 3.50K | 7.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.90K | 17.90K | 19.80K | 24.70K | 9.70K |
|
|
|||||
| Total Current Assets | 8.90K | 17.90K | 19.80K | 24.70K | 9.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.38M | 1.38M | 1.47M | 1.46M | 1.46M |
|
|
|||||
| Total Accounts Payable | 394.60K | 417.70K | 291.90K | 288.20K | 262.60K |
| Total Accrued Expenses | 17.40K | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 30.60K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 2.70K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 412.00K | 417.70K | 291.90K | 321.50K | 262.60K |
|
|
|||||
| Total Current Liabilities | 412.00K | 417.70K | 291.90K | 321.50K | 262.60K |
| Long-Term Debt | 36.00K | 34.50K | 35.20K | -- | 32.30K |
| Short-term Debt | -- | -- | -- | 30.60K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 447.90K | 452.20K | 327.10K | 321.50K | 294.80K |
|
|
|||||
| Common Stock & APIC | 12.30M | 12.29M | 13.08M | 12.92M | 13.05M |
| Retained Earnings | -16.59M | -16.56M | -17.49M | -17.25M | -17.42M |
| Treasury Stock & Other | 5.22M | 5.21M | 5.55M | 5.48M | 5.54M |
| Total Common Equity | 928.40K | 931.80K | 1.15M | 1.14M | 1.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 928.40K | 931.80K | 1.15M | 1.14M | 1.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 928.40K | 931.80K | 1.15M | 1.14M | 1.17M |
|
|
|||||